Venous thromboembolism in cancer patients: a call for more awareness

by Delluc, A., Carrier, M.
Published 2014

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai‐VTE study

by Scheres, LJJ, Brekelmans, MPA, Ageno, W, Ay, C, Büller, HR, Eichinger, S, Hutten, BA, Klok, FA, Middeldorp, S, Schreiber, K, Stach, K, Blondon, M, Delluc, A
Published in BJOG (2018)

Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk

by Suchon, P., Germain, M., Delluc, A., Smadja, D., Jouven, X., Gyorgy, B., Saut, N., Ibrahim, M., Deleuze, J. F., Alessi, M. C., Morange, P. E., Trégouët, D. A.
Published in Sci Rep (2017)

Is there still room for additional common susceptibility alleles for venous thromboembolism?

by Trégouët, D-A, Delluc, A., Roche, A., Derbois, C., Olaso, R., Germain, M., de Andrade, M., Tang, W., Chasman, D. I., van Hylckama Vlieg, A., Reitsma, P., Kabrhel, C., Smith, N., Morange, P-E.
Published in J Thromb Haemost (2016)